Government of Congo Report issue

Government Phase 4

Organization Overview

First Clinical Trial
2020
NCT04618523
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2022

Timeline

NOW
  • Now

Alternative names

INRB | Institut National de Recherche Biomédicale. Kinshasa, République Démocratique du Congo | Institut National de Research Biomédicale